Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso

The WHO recommends that children living in areas of highly seasonal malaria transmission in the Sahel subregion should receive seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine plus amodiaquine (SPAQ). We evaluated the use of dihydroartemisinin-piperaquine (DHAPQ) as an alternati...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Antimicrob Agents Chemother
Главные авторы: Zongo, Issaka, Milligan, Paul, Compaore, Yves Daniel, Some, A. Fabrice, Greenwood, Brian, Tarning, Joel, Rosenthal, Philip J., Sutherland, Colin, Nosten, Francois, Ouedraogo, Jean-Bosco
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2015
Предметы:
Epidemiology and Surveillance
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4505196/
https://ncbi.nlm.nih.gov/pubmed/25918149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04923-14
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы